Ignite Creation Date:
2025-12-24 @ 4:47 PM
Ignite Modification Date:
2025-12-31 @ 1:01 AM
Study NCT ID:
NCT05239650
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-05-03
First Post:
2022-02-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC
Sponsor:
Shanghai Henlius Biotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-10-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-15
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-07
First Submit QC Date:
None
Study First Post Date:
2022-02-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-01
Last Update Post Date:
2022-05-03
Last Update Post Date Type:
ACTUAL